Publications by authors named "A Durieux"

The FoVE model is a new theoretical framework coupled with innovative modeling to evaluate the striated skeletal muscle function. The theoretical model is based on two fundamental relationships: the force-velocity relationship and the force-time relationship. These relationships describe the muscle force production capacity as a function of contraction velocity and exercise duration, respectively.

View Article and Find Full Text PDF

Background: Astronauts in Earth's orbit experience microgravity, resulting in a decline of skeletal muscle mass and function. On Earth, models simulating microgravity have shown that the extent of the loss in muscle force is greater than the loss in muscle mass. The reasons behind this disproportionate loss of muscle force are still poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Sepsis in ICU patients leads to muscle mass loss and decreased function, contributing to long-term disability.
  • A study tested whether disabling the myostatin gene, which normally inhibits muscle growth, could help prevent muscle wasting in septic mice, but results showed no benefits.
  • Both wild-type and myostatin knock-out mice experienced similar muscle mass and strength loss after sepsis, suggesting that targeting myostatin may not effectively improve outcomes in muscle wasting related to sepsis.
View Article and Find Full Text PDF

We present for the first-time efficacy and tolerability of GLP-1-RA (Semaglutide) in Smith-Kingsmore syndrome (SKS). SKS is a rare genetic disorder characterized by intellectual disability, macrocephaly, seizures and distinctive facial features due to MTOR gene mutation. We present a 22-year-old woman with mosaic SKS and severe obesity (Body Mass Index ≥40 kg/m²), treated with semaglutide.

View Article and Find Full Text PDF

Background: Cancer patients at advanced stages experience a severe depletion of skeletal muscle compartment together with a decrease in muscle function, known as cancer cachexia. Cachexia contributes to reducing quality of life, treatment efficiency, and lifespan of cancer patients. However, the systemic nature of the syndrome is poorly documented.

View Article and Find Full Text PDF